What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

VALUE ADDED MEDICINES ONLINE SUMMIT Empowering the healthcare community by improving existing treatments

23 April 2021

Report

Open

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2021

Policy

Open

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

10 February 2021

Report

Open

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

Open

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Factsheet

Open

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Open

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Open

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Open

COVID-19 “Round 2” – Findings & way forward (Kearney)

22 June 2020

Report

Open

Subscribe to our newsletter